14-104948942-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_138420.4(AHNAK2):​c.6509A>G​(p.Lys2170Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K2170E) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.044 ( 173 hom., cov: 19)
Exomes 𝑓: 0.12 ( 49964 hom. )
Failed GnomAD Quality Control

Consequence

AHNAK2
NM_138420.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.84

Publications

6 publications found
Variant links:
Genes affected
AHNAK2 (HGNC:20125): (AHNAK nucleoprotein 2) This gene encodes a large nucleoprotein. The encoded protein has a tripartite domain structure with a relatively short N-terminus and a long C-terminus, separated by a large body of repeats. The N-terminal PSD-95/Discs-large/ZO-1 (PDZ)-like domain is thought to function in the formation of stable homodimers. The encoded protein may play a role in calcium signaling by associating with calcium channel proteins. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2017]
AHNAK2 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease
    Inheritance: AR Classification: LIMITED Submitted by: Illumina, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0016698241).
BP6
Variant 14-104948942-T-C is Benign according to our data. Variant chr14-104948942-T-C is described in ClinVar as [Benign]. Clinvar id is 402352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AHNAK2NM_138420.4 linkc.6509A>G p.Lys2170Arg missense_variant Exon 7 of 7 ENST00000333244.6 NP_612429.2 Q8IVF2-1
AHNAK2NM_001350929.2 linkc.6209A>G p.Lys2070Arg missense_variant Exon 7 of 7 NP_001337858.1
AHNAK2XM_024449463.2 linkc.6209A>G p.Lys2070Arg missense_variant Exon 7 of 7 XP_024305231.1
AHNAK2XM_047430904.1 linkc.6209A>G p.Lys2070Arg missense_variant Exon 7 of 7 XP_047286860.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AHNAK2ENST00000333244.6 linkc.6509A>G p.Lys2170Arg missense_variant Exon 7 of 7 5 NM_138420.4 ENSP00000353114.4 Q8IVF2-1
AHNAK2ENST00000557457.1 linkc.-221+4939A>G intron_variant Intron 1 of 2 1 ENSP00000450998.1 Q8IVF2-2
AHNAK2ENST00000555122.1 linkn.6637A>G non_coding_transcript_exon_variant Exon 6 of 6 5

Frequencies

GnomAD3 genomes
AF:
0.0437
AC:
3784
AN:
86654
Hom.:
174
Cov.:
19
show subpopulations
Gnomad AFR
AF:
0.0440
Gnomad AMI
AF:
0.0461
Gnomad AMR
AF:
0.0389
Gnomad ASJ
AF:
0.0666
Gnomad EAS
AF:
0.00503
Gnomad SAS
AF:
0.0444
Gnomad FIN
AF:
0.0489
Gnomad MID
AF:
0.0962
Gnomad NFE
AF:
0.0482
Gnomad OTH
AF:
0.0498
GnomAD2 exomes
AF:
0.0966
AC:
19334
AN:
200092
AF XY:
0.104
show subpopulations
Gnomad AFR exome
AF:
0.0424
Gnomad AMR exome
AF:
0.0597
Gnomad ASJ exome
AF:
0.239
Gnomad EAS exome
AF:
0.00577
Gnomad FIN exome
AF:
0.0410
Gnomad NFE exome
AF:
0.124
Gnomad OTH exome
AF:
0.155
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.120
AC:
130577
AN:
1090618
Hom.:
49964
Cov.:
104
AF XY:
0.124
AC XY:
67073
AN XY:
542508
show subpopulations
African (AFR)
AF:
0.0423
AC:
1299
AN:
30718
American (AMR)
AF:
0.0610
AC:
2183
AN:
35774
Ashkenazi Jewish (ASJ)
AF:
0.262
AC:
4546
AN:
17334
East Asian (EAS)
AF:
0.00334
AC:
126
AN:
37700
South Asian (SAS)
AF:
0.158
AC:
10001
AN:
63388
European-Finnish (FIN)
AF:
0.0828
AC:
3227
AN:
38988
Middle Eastern (MID)
AF:
0.178
AC:
673
AN:
3776
European-Non Finnish (NFE)
AF:
0.126
AC:
103087
AN:
818862
Other (OTH)
AF:
0.123
AC:
5435
AN:
44078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.724
Heterozygous variant carriers
0
1610
3220
4829
6439
8049
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1886
3772
5658
7544
9430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0436
AC:
3786
AN:
86786
Hom.:
173
Cov.:
19
AF XY:
0.0431
AC XY:
1841
AN XY:
42704
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0440
AC:
1490
AN:
33898
American (AMR)
AF:
0.0387
AC:
350
AN:
9040
Ashkenazi Jewish (ASJ)
AF:
0.0666
AC:
78
AN:
1172
East Asian (EAS)
AF:
0.00526
AC:
23
AN:
4372
South Asian (SAS)
AF:
0.0445
AC:
105
AN:
2358
European-Finnish (FIN)
AF:
0.0489
AC:
275
AN:
5618
Middle Eastern (MID)
AF:
0.0943
AC:
10
AN:
106
European-Non Finnish (NFE)
AF:
0.0482
AC:
1382
AN:
28682
Other (OTH)
AF:
0.0480
AC:
52
AN:
1084
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.344
Heterozygous variant carriers
0
252
505
757
1010
1262
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.353
Hom.:
3610
ExAC
AF:
0.121
AC:
14301

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
17
DANN
Uncertain
1.0
DEOGEN2
Benign
0.021
T
Eigen
Benign
0.080
Eigen_PC
Benign
-0.099
FATHMM_MKL
Benign
0.15
N
LIST_S2
Benign
0.64
T
MetaRNN
Benign
0.0017
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.4
L
PhyloP100
1.8
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-0.89
N
REVEL
Benign
0.13
Sift
Benign
0.78
T
Sift4G
Benign
0.68
T
Polyphen
0.99
D
Vest4
0.066
ClinPred
0.018
T
GERP RS
4.0
Varity_R
0.028
gMVP
0.0033
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201127689; hg19: chr14-105415279; COSMIC: COSV60910083; COSMIC: COSV60910083; API